ZION
52
3
HBAN
47
3
NWSA
75
8
MAT
43
2
MSFT
58
4
EMR
62
6
IVZ
48
3
MPC
31
3
HSY
34
3
KR
50
4
URI
39
3
TXN
35
5
AMT
33
3
PVH
62
4
R
61
2
KO
46
4
PNR
60
3
FMC
22
2
TEL
60
2
BK
61
3
ZION
52
3
HBAN
47
3
NWSA
75
8
MAT
43
2
MSFT
58
4
EMR
62
6
IVZ
48
3
MPC
31
3
HSY
34
3
KR
50
4
URI
39
3
TXN
35
5
AMT
33
3
PVH
62
4
R
61
2
KO
46
4
PNR
60
3
FMC
22
2
TEL
60
2
BK
61
3
Financhill
Back

Trinity Biotech PLC 10K Form

Sell
19

TRIB
Trinity Biotech PLC

Last Price:
$0.84
Seasonality Move:
12.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRIB News And Ratings

See the #1 stock for the next 7 days that we like better than TRIB

TRIB Financial Statistics

Sales & Book Value

Annual Sales: $56.8M
Cash Flow: $-6.3M
Price / Cash Flow: 0
Annual Sales: $-2.78
Price / Book: 0

Profitability

EPS (TTM): -2.28000
Net Income (TTM): $-20.3M
Gross Margin: $19.5M
Return on Equity: 0%
Return on Assets: -25.1%

Trinity Biotech PLC Earnings Forecast

Key Trinity Biotech PLC Financial Ratios

  • The Gross Profit Margin over the past 30 years for TRIB is 34.22%.
  • The Selling, General & Administrative Expenses for TRIB have been equal to 54.81% of Gross Profit Margin.
  • The Research & Development expenses have been 7.71% of Revenue.
  • The Interest Expense is -42.25% of Operating Income.
  • The Net Earning history of TRIB is -42.26% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 15 years.

Trinity Biotech PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TRIB
CUSIP: 896438
Website: trinitybiotech.com

Debt

Debt-to-Equity Ratio: -3.11
Current Ratio: 1.64
Quick Ratio: 0.87

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRIB Technical Analysis vs Fundamental Analysis

Sell
19
Trinity Biotech PLC (TRIB) is a Sell

Is Trinity Biotech PLC a Buy or a Sell?